Dr George Thomas Manilla, MD | |
1275 Hannah Dr, Elko, NV 89801-2523 | |
(775) 738-3031 | |
Not Available |
Full Name | Dr George Thomas Manilla |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1275 Hannah Dr, Elko, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093064925 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2047 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr George Thomas Manilla, MD 1275 Hannah Dr, Elko, NV 89801-2523 Ph: (775) 738-3031 | Dr George Thomas Manilla, MD 1275 Hannah Dr, Elko, NV 89801-2523 Ph: (775) 738-3031 |
News Archive
A new study by researchers from Brigham and Women's Hospital in Boston, Massachusetts reveals that Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower mortality rates compared to Black, White, or Native Americans with the disease.
Building on a longstanding commitment to developing diversity in the biomedical science research workforce, AGA is pleased to announce the funding of a new initiative, the AGA FORWARD PROGRAM: Fostering Opportunities Resulting in Workforce and Research Diversity, supported by NIH (1R25DK118761-01).
BioTrends Research Group, Inc. recently published its TreatmentTrends: Renal Anemia in China report. This report is based on survey results from 150 nephrologists in clinical practice in China and qualitative interviews conducted with ten thought leaders in nephrology. The report examines the demographics of nephrology practice in China and focuses specifically on the management of renal anemia amongst dialysis and later stage chronic kidney disease patients.
CeltiCare Health Plan of Massachusetts, a Centene Corporation subsidiary, today announced that the state of Massachusetts has renewed its contract to serve Commonwealth Care Bridge Program members, effective July 1, 2010.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip for its lead product, MuGard - an FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy.
› Verified 7 days ago
George Mardini, MD Pathology Medicare: Medicare Enrolled Practice Location: 1250 Lamoille Hwy, Elko, NV 89801 Phone: 775-753-5845 |